AZTA
Azenta, Inc. · Healthcare · Medical - Instruments & Supplies
Momentum inputs (comparable managers):
holder breadth +10.0% ·
share flow +10.8% ·
net new positions +9.1%
· formula
Broad accumulation: rising shares across more holders
All ownership figures: tracked 13F managers only, common-stock positions, reporting period Q4 2024
| Quarter | Holders | Δ | Shares | Reported value | New | Exits |
|---|---|---|---|---|---|---|
| Q3 2026 | 3 | +1 | 120.54K | $3.93M | +1 | n/a |
| Q2 2026 | 95 | +4 | 31.71M | $809.28M | +12 | −7 |
| Q1 2026 | 93 | -11 | 30.54M | $644.99M | +6 | −17 |
| Q4 2025 | 103 | -1 | 32.89M | $1.09B | +1 | −2 |
| Q3 2025 | 16 | -1 | 19.69M | $565.39M | n/a | −1 |
| Q2 2025 | 14 | 0 | 18.89M | $581.53M | +1 | −1 |
| Q1 2025 | 11 | 0 | 5.08M | $176.05M | +1 | −1 |
| Q4 2024 | 11 | +1 | 5.23M | $261.74M | +1 | n/a |
| Q3 2024 | 9 | +1 | 2.97M | $143.74M | +1 | n/a |
| Q2 2024 | 8 | n/a | 3.27M | $172.22M | n/a | n/a |
| # | Manager | Shares | Δ shares | Value | Their weight | Held | ||
|---|---|---|---|---|---|---|---|---|
| 1 | State Street Global Advisors ✦ (passive) | 1.76M | n/a | $87.89M | 0.0% | n/c | 1 | SEC ↗ |
| 2 | Geode Capital Management ✦ (passive) | 782.75K | -11.9% | $39.15M | 0.0% | ▼ Trim | 3 | SEC ↗ ×2 |
| 3 | Fisher Asset Management ✦ | 771.81K | -6.8% | $38.59M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 4 | Norges Bank ✦ (passive) | 508.06K | -2.6% | $25.40M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 5 | Marshall Wace ✦ | 409.38K | New | $20.47M | 0.0% | New | 1 | SEC ↗ ×2 |
| 6 | D. E. Shaw & Co. ✦ | 300.78K | -35.4% | $15.04M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 7 | Gotham Asset Management ✦ | 198.05K | +388.2% | $9.90M | 0.1% | ▲ Add | 3 | SEC ↗ |
| 8 | Citadel Advisors ✦ | 193.12K | +388.9% | $9.66M | 0.0% | ▲ Add | 3 | SEC ↗ ×2 |
| 9 | Two Sigma Investments ✦ | 172.79K | +178.5% | $8.64M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 10 | Millennium Management ✦ | 108.17K | +19.8% | $5.41M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 11 | T. Rowe Price ✦ | 31.85K | +4.5% | $1.59M | 0.0% | ▲ Add | 3 | SEC ↗ |
“Their weight” = the position's share of that manager's reported 13F equity value: the conviction measure. ✦ = curated manager.
New buyers
| Marshall Wace | $20.47M | 0.0% |
Exited
| No tracked exits this quarter. |
Full-market context: across ALL 13F filers (SEC structured data, Q1 2026): 256 holders, 52.74M shares, $1.06B reported. This is a different, older period than the tracked-universe figures above and the two are never mixed.
What else this security's tracked holders most often hold: shared-ownership counts, not fundamental relationships.